{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:09:05Z","timestamp":1792804145655,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009104","name":"Department of Health Research, India","doi-asserted-by":"publisher","award":["DHR-R.110013\/68\/2021-GIA\/HR"],"award-info":[{"award-number":["DHR-R.110013\/68\/2021-GIA\/HR"]}],"id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuroscience.2025.10.014","type":"journal-article","created":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T14:23:25Z","timestamp":1760279005000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Neurobiochemical alterations in patients with idiopathic Parkinson\u2019s disease in sensorimotor cortex using 1H-MRS"],"prefix":"10.1016","volume":"588","author":[{"given":"Sadhana","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4275-0139","authenticated-orcid":false,"given":"S Senthil","family":"Kumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4505-0506","authenticated-orcid":false,"given":"Shefali","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-7947","authenticated-orcid":false,"given":"Achal Kumar","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Anthony Edward","family":"Edden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.10.014_b0005","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuroimage.2005.02.018","article-title":"Unified segmentation","volume":"26","author":"Ashburner","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.parkreldis.2017.07.028","article-title":"Thalamic neurometabolic alterations in tremulous Parkinson\u2019s disease: a preliminary proton MR spectroscopy study","volume":"43","author":"Barbagallo","year":"2017","journal-title":"Parkinsonism Related Disord."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0015","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/jnc.15516","article-title":"The role of neuroimaging in Parkinson\u2019s disease","volume":"159","author":"Bidesi","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0020","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3390\/jcm11071931","article-title":"Effect of MAO-B inhibitors on neurometabolic profile of patients affected by parkinson disease: a proton magnetic resonance spectroscopy study","volume":"11","author":"Bonanno","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0025","first-page":"997","article-title":"Identification of metabolic correlates of mild cognitive impairment in Parkinson\u2019s disease using magnetic resonance spectroscopic imaging and machine learning","volume":"35","author":"Cengiz","year":"2022","journal-title":"Magma (new York, n.y.)"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0030","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1471-4159.2007.05185.x","article-title":"Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson\u2019s disease, the MPTP-intoxicated mouse","volume":"105","author":"Chassain","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00004424-199808000-00005","article-title":"Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy","volume":"33","author":"Choe","year":"1998","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.parkreldis.2022.05.007","article-title":"Glutamate cycle changes in the putamen of patients with de novo Parkinson\u2019s disease using (1)H MRS","volume":"99","author":"Chassain","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0045","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10072-020-04626-9","article-title":"Frontal lobe metabolic alterations characterizing Parkinson\u2019s disease cognitive impairment","volume":"42","author":"Chaudhary","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neulet.2015.05.044","article-title":"Metabolic changes in de novo Parkinson\u2019s disease after dopaminergic therapy: a proton magnetic resonance spectroscopy study","volume":"599","author":"Ciurleo","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/nbm.2817","article-title":"An in vivo ultrahigh field 14.1 T (1) H-MRS study on 6-OHDA and \u03b1- synuclein-based rat models of Parkinson\u2019s disease: GABA as an early disease marker","volume":"26","author":"Coune","year":"2013","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0060","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/mds.28221","article-title":"High \u03b3- aminobutyric acid content within the medial prefrontal cortex is a functional signature of somatic symptoms disorder in patients with Parkinson\u2019s Disease","volume":"35","author":"Delli Pizzi","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fnhum.2019.00111","article-title":"Fast intracortical sensory- motor integration: a window into the pathophysiology of parkinson\u2019s disease","volume":"13","author":"Dubbioso","year":"2019","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0070","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/jmri.24478","article-title":"Gannet: a batch-processing tool for the quantitative analysis of GABA-edited MRS spectra","volume":"4","author":"Edden","year":"2014","journal-title":"J. Magn. Reson. Imag."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/cjn.2015.244","article-title":"Early-onset vs. Late-onset Parkinson\u2019s disease: a Clinical-pathological Study","volume":"43","author":"Ferguson","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.10.014_b0080","first-page":"1","article-title":"Alterations in neuronal activity in basal ganglia- thalamocortical circuits in the Parkinsonian State","volume":"9","author":"Galvan","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0085","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/jmri.25865","article-title":"Inhibitory motor dysfunction in Parkinson\u2019s disease subtypes","volume":"47","author":"Gong","year":"2018","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0090","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/nbm.1203","article-title":"Reduced brain glutamate in patients with Parkinson\u2019s disease","volume":"21","author":"Griffith","year":"2008","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.838230","article-title":"Proton magnetic resonance spectroscopy for the early diagnosis of Parkinson disease in the substantia nigra and globus pallidus: a meta-analysis with trial sequential analysis","volume":"13","author":"Gu","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0100","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/jmri.24903","article-title":"Tissue correction for GABA-edited MRS: considerations of voxel composition, tissue segmentation, and tissue relaxations","volume":"42","author":"Harris","year":"2015","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0105","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","article-title":"Improved accuracy of clinical diagnosis of Lewy body Parkinson\u2019s disease","volume":"57","author":"Hughes","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0110","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","article-title":"FSL","volume":"62","author":"Jenkinson","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0115","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/WNL.41.2_Part_1.202","article-title":"Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson\u2019s disease","volume":"41","author":"Kostic","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.14802\/jmd.15003","article-title":"Many faces of parkinson\u2019s disease: non-motor symptoms of Parkinson\u2019s Disease","volume":"8","author":"Lee","year":"2015","journal-title":"J. Movement Disord."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0125","first-page":"202","article-title":"Sensorimotor cortex neurometabolite levels as correlate of motor performance in normal aging: evidence from a 1H-MRS study","volume":"15","author":"Levin","year":"2019","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/nbm.4484","article-title":"Minimum reporting standards for in vivo magnetic resonance spectroscopy (MRSinMRS): experts\u2019 consensus recommendations","volume":"34","author":"Lin","year":"2021","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0135","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1523\/JNEUROSCI.2883-19.2020","article-title":"Regional myo-inositol, creatine, and choline levels are higher at older age and scale negatively with visuospatial working memory: a cross-sectional proton mr spectroscopy study at 7 tesla on normal cognitive ageing","volume":"40","author":"Lind","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0140","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1523\/JNEUROSCI.1318-16.2016","article-title":"The role of primary motor cortex (M1) glutamate and GABA signaling in L-DOPA-induced dyskinesia in parkinsonian rats","volume":"36","author":"Lindenbach","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0145","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1471-4159.2003.01905.x","article-title":"Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain","volume":"86","author":"Madhavarao","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0150","doi-asserted-by":"crossref","unstructured":"Martel, A. C., & Galvan, A. (2023). Corrigendum to: \u201cConnectivity of the Corticostriatal and Thalamostriatal Systems in Normal and Parkinsonian States: An Update\u201d Neurobiology of Disease. Neurobiology of Disease, 177, 1\u201336. Doi: 10.1016\/j.nbd.2022.105985.","DOI":"10.1016\/j.nbd.2022.105985"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1148\/radiol.2015142764","article-title":"Proton MR spectroscopy for diagnosis and evaluation of treatment efficacy in Parkinson disease","volume":"278","author":"Mazuel","year":"2016","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.10.014_b0165","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/mdc3.13523","volume":"10","author":"Mehanna","year":"2022","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J","article-title":"Simultaneous in vivo spectral editing and water suppression","volume":"11","author":"Mescher","year":"1998","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jocn.2024.05.015","article-title":"Global prevalence and incidence of Young Onset Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"125","author":"Nabizadeh","year":"2024","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0180","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/mds.22062","article-title":"Functional organization of the basal ganglia: Therapeutic implications for Parkinson\u2019s disease","volume":"23","author":"Obeso","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0185","first-page":"1","article-title":"Beyond dopamine: GABA, glutamate, and the axial symptoms of Parkinson disease","volume":"9","author":"O\u2019Gorman Tuura","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0028-3932(71)90067-4","article-title":"The assessment and analysis of handedness: the Edinburgh inventory","volume":"9","author":"Oldfield","year":"1971","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0195","doi-asserted-by":"crossref","unstructured":"\u00d6z, G., et al. (2014). Clinical proton MR spectroscopy in central nervous system disorders. In Radiology. Radiological Society of North America Inc. 270, 658\u2013679. Doi: 10.1148\/radiol.13130531.","DOI":"10.1148\/radiol.13130531"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0200","first-page":"1","article-title":"Cerebellar gaba levels and cognitive interference in Parkinson\u2019s disease and healthy comparators","volume":"11","author":"Piras","year":"2021","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0205","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0210","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0215","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","article-title":"Automatic quantitation of localized in vivo 1H spectra with LCModel","volume":"14","author":"Provencher","year":"2001","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0220","doi-asserted-by":"crossref","first-page":"15761","DOI":"10.1038\/s41598-020-72321-y","article-title":"Laterality of specific binding ratios on DAT-SPECT for differential diagnosis of degenerative parkinsonian syndromes","volume":"10","author":"Shigekiyo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0225","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1474-4422(06)70411-2","article-title":"Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism","volume":"5","author":"Schrag","year":"2006","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0230","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/mds.26323","article-title":"Longitudinal study of the substantia nigra in Parkinson disease: a high-field 1H-MR spectroscopy imaging study","volume":"30","author":"Seraji-Bozorgzad","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0235","first-page":"156","article-title":"Brain proton magnetic resonance spectroscopy in patients with Parkinson\u2019s disease","volume":"21","author":"Shoeibi","year":"2022","journal-title":"Curr. J. Neurol."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0240","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1089\/08977150152693683","article-title":"N-Acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury","volume":"18","author":"Signoretti","year":"2001","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.crad.2008.07.002","article-title":"Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications","volume":"64","author":"Soares","year":"2009","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0250","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10334-021-00910-7","article-title":"Upper brainstem GABA levels in Parkinson\u2019s disease","volume":"34","author":"Song","year":"2021","journal-title":"MAGMA"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.619631","article-title":"Motor symptom lateralization influences cortico-striatal functional connectivity in Parkinson's Disease","volume":"12","author":"Su","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0260","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/00207454.2015.1010646","article-title":"Cognitive profile of Parkinson\u2019s disease patients: a comparative study between early-onset and late-onset Parkinson\u2019s disease","volume":"126","author":"Tang","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0265","article-title":"Unveiling MRI markers for Parkinson\u2019s Disease: GABAergic dysfunction and cortical changes","volume":"43","author":"Tian","year":"2024","journal-title":"NeuroImage: Clinical"},{"key":"10.1016\/j.neuroscience.2025.10.014_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105159","article-title":"Primary motor cortex in Parkinson\u2019s disease: Functional changes and opportunities for neurostimulation","volume":"147","author":"Underwood","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0275","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hbm.24857","article-title":"GABAergic changes in the thalamocortical circuit in Parkinson\u2019s disease","volume":"41","author":"van Nuland","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0280","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.585584","article-title":"Molecular mechanisms of glutamate toxicity in Parkinson\u2019s disease","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0285","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/mrm.27742","article-title":"Spectroscopy of the brain\u00a0: review and recommendations","volume":"82","author":"Wilson","year":"2019","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neuroscience.2025.10.014_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2025.103740","article-title":"Neurotransmitter imbalance, glutathione depletion and concomitant susceptibility increase in Parkinson\u2019s disease","volume":"45","author":"Yan","year":"2025","journal-title":"NeuroImage. Clin."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225010061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225010061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:56:55Z","timestamp":1778745415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225010061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":57,"alternative-id":["S0306452225010061"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.10.014","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurobiochemical alterations in patients with idiopathic Parkinson\u2019s disease in sensorimotor cortex using 1H-MRS","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}